Bioresorbable Polymers Market Analysis

Q: What is the key market trend for Bioresorbable Polymers Market?

Growing Demand for Medical Applications: Increasing usage of bioresorbable polymers in medicine is being noticed due to the special feature of being naturally degraded within the body and hence not requiring surgical removal. They are most valuable in applications like drug delivery systems, tissue engineering, and surgical sutures. They also have a broad range of applications in orthopedic implants, cardiovascular devices, and wound healing. As the global healthcare market expands with the aging population and its increasing demand for minimally invasive procedures, bioresorbable polymers will see increased demand.

Bioresorbable Polymers Market Dynamics

Drivers

Increasing Focus on Sustainable and Eco-Friendly Materials

As environmental sustainability continues to gain momentum, bioresorbable polymers are positioned as the more sustainable substitute to traditional plastics. Industries such as packaging, automotive, and agriculture are increasingly seeking sustainable materials that naturally decompose, and bioresorbable polymers offer a promising solution. Increasing plastic waste concerns and heightened regulatory pressure on environmental impact are pushing these materials into diverse non-medical applications.

Increasing Demand for Bioresorbable Polymers

Polymers have significantly contributed to the improvement of drug delivery technology by enabling the regulated release of therapeutic agents in consistent dosages over extended periods, cyclic dosing, and various releases of both hydrophilic and hydrophobic medicines. The area has expanded significantly from its early days of employing common materials. The rational design of polymers made to exert certain biological activities and customized for a specific cargo is currently the foundation for contemporary advancements in drug delivery.

Restraints

Increasing Preference for Minimally Invasive Surgeries

The preference for minimally invasive surgeries is increasing due to the associated benefits, which include short stays in hospitals, faster recovery, minimal bleeding and pain. However, this shift in preference toward more minimally invasive procedures as opposed to the conventional mode of surgery has also resulted in the reduced demand for different kinds of medical devices, thereby limiting the growth of the market. Laparoscopy is considered one of the most popular forms of minimally invasive surgeries in which several tiny incisions of 0.5-1.5 cm are made in the abdomen or pelvic area.

Stringent Regulatory Framework for Medical Devices

The innovation of bioresorbable medical devices is an expensive exercise, usually requiring more than 7–8 years to get the product on the market. In the US. For instance, the FDA requires manufacturers of bioabsorbable devices to obtain a Premarket Approval (PMA), which has several filing requirements and clinical trial data to be submitted with the filing. Developmental costs and high risks prohibit more than two-thirds of the products from ever advancing into the clinical trial stages. The burden of acquiring clinically meaningful trial data is also high.

FAQs

Global Bioresorbable Polymers Market size was valued at USD 1110.19 Million in 2023 and is poised to grow from USD 1254.52 Million in 2024 to USD 3335.07 Million by 2032, growing at a CAGR of 13% in the forecast period (2025-2032).

The global bioresorbable polymers industry is highly competitive, with key players focusing on innovation, strategic partnerships, and expanding their product portfolios to maintain a strong market presence. Corbion N.V. is a global leader in sustainable solutions, specializing in lactic acid and its derivatives, which are used in medical applications such as drug delivery systems and sutures. Evonik Industries AG is another major player, offering high-performance bioresorbable polymers designed for implantable devices, tissue engineering, and controlled drug release applications. 'Corbion NV', 'Evonik Industries AG', 'Poly-Med Inc.', 'Foster Corp.', 'Abbott', 'Merck KGaA', 'Royal DSM NV. ', 'Ashland ', 'Sigma-Aldrich ', 'Mar-Lee Companies ', 'LACTEL Absorbable Polymers ', 'Galatea Surgical ', 'KAO Corporation', 'KLS Martin Group', '3D Biotek LLC.', 'Sunstar Suisse S.A.', 'DSM', 'Futerro'

As environmental sustainability continues to gain momentum, bioresorbable polymers are positioned as the more sustainable substitute to traditional plastics. Industries such as packaging, automotive, and agriculture are increasingly seeking sustainable materials that naturally decompose, and bioresorbable polymers offer a promising solution. Increasing plastic waste concerns and heightened regulatory pressure on environmental impact are pushing these materials into diverse non-medical applications.

Growing Demand for Medical Applications: Increasing usage of bioresorbable polymers in medicine is being noticed due to the special feature of being naturally degraded within the body and hence not requiring surgical removal. They are most valuable in applications like drug delivery systems, tissue engineering, and surgical sutures. They also have a broad range of applications in orthopedic implants, cardiovascular devices, and wound healing. As the global healthcare market expands with the aging population and its increasing demand for minimally invasive procedures, bioresorbable polymers will see increased demand.

North America dominated the industry and accounted for the largest revenue share of 33.5% in 2024. This is attributed to the increasing product consumption in drug delivery and orthopedics applications in the region. The U.S. is the major hub for research & development in the healthcare industry, further driving the market growth in North America. Moreover, the rising demand for orthopedics and drug delivery applications supports the bioresorbable polymers demand in the region. According to the data provided by the American Joint Replacement Registry (AJRR) in 2022, over 2.8 million knee and hip procedures were performed across 1,250 health institutions in the U.S. This signifies a remarkable 14% increase in cumulative registered procedural volume compared to the previous year, establishing the AJRR as the world's largest arthroplasty registry in terms of volume.